AI TextQuick Glance (AI)Headnote
Issues: (i) Whether the goods were classifiable as medicaments under Chapter 30 or as cosmetics under Chapter 33 of the Central Excise Tariff Act, 1985. (ii) Whether duty liability for the period prior to August 2011 could be fastened on the loan licence holder when the goods were manufactured by the job worker. (iii) Whether the appellant was entitled to SSI exemption for the period September 2011 to February 2012 and, consequently, whether any differential duty or penalty survived.
Issue (i): Whether the goods were classifiable as medicaments under Chapter 30 or as cosmetics under Chapter 33 of the Central Excise Tariff Act, 1985.
Analysis: The goods were manufactured under Ayurvedic drug licences issued by the competent drug licensing authority, and the record showed that the products were described and approved as Ayurvedic medicines. The classification dispute was resolved by applying the therapeutic and prophylactic character of the products, the licensed Ayurvedic formulation framework, and the principles recognised in classification jurisprudence for distinguishing medicaments from cosmetics. The revenue's reliance on cosmetic classification was found inapposite on the facts.
Conclusion: The goods were held to be medicaments classifiable under Chapter 30, not cosmetics under Chapter 33.
Issue (ii): Whether duty liability for the period prior to August 2011 could be fastened on the loan licence holder when the goods were manufactured by the job worker.
Analysis: Duty under central excise is fastened on the manufacturer. The manufacturing for the relevant period was carried out by the job worker under the loan licence arrangement, and the fact that the loan licence holder had obtained drug licence recognition did not convert it into the manufacturer for excise purposes. The circumstance that the job worker was treated as not liable in the impugned order could not be used to shift duty liability to the loan licence holder.
Conclusion: The loan licence holder was not liable for central excise duty for the period prior to August 2011.
Issue (iii): Whether the appellant was entitled to SSI exemption for the period September 2011 to February 2012 and, consequently, whether any differential duty or penalty survived.
Analysis: For the relevant period, the turnover remained within the SSI exemption limit under the notification relied upon, and once the goods were held to be medicaments, the concessional regime applied. After registration, duty was being paid on the correct classification, so no differential demand survived. In the facts found, the demand and the consequential penalties could not be sustained.
Conclusion: The appellant was entitled to SSI exemption for September 2011 to February 2012, and no differential duty or penalty survived.
Final Conclusion: The classification adopted by the appellant was accepted, the pre-August 2011 demand was unsustainable against the loan licence holder, the SSI benefit was available for the relevant intermediate period, and the connected penalties were set aside.
Ratio Decidendi: Goods manufactured under a valid Ayurvedic drug licence and shown to possess therapeutic or prophylactic character are classifiable as medicaments under Chapter 30, and excise duty cannot be shifted to a loan licence holder unless it is the manufacturer in law for central excise purposes.
Ayurvedic medicament classification and excise liability: Chapter 30 treatment, no duty shift to loan licence holder, SSI relief applied.
Goods manufactured under a valid Ayurvedic drug licence and shown to have therapeutic or prophylactic character were classified as medicaments under Chapter 30, not cosmetics under Chapter 33. Central excise duty for the pre-August 2011 period could not be fastened on the loan licence holder because duty attaches to the manufacturer, and the goods were made by the job worker. For September 2011 to February 2012, SSI exemption applied on the facts found, so no differential duty or penalty survived. The connected demands and penalties were set aside.
Classification of goods - classifiable as medicaments under Chapter 30 Or as cosmetics under Chapter 33 - twin test (ingredient and common parlance) - loan licence - burden of proof - liability to pay central excise duty for goods manufactured by the job worker - limitation and extended period requires suppression or wilful misstatement - SSI exemption entitlement under Notification No. 08/2003-C.E. - demands, interest and penalties. Classification of goods - HELD THAT:- The Tribunal held that the products are Ayurvedic medicines/medicaments. The finding rests on the licences and certificates issued by the Directorate of ISM Drugs Control and Manufacture under the relevant drug licences, conformity of ingredients and dosages with authoritative Ayurvedic texts, and precedent including Sharma Chemical Works [2003 (4) TMI 102 - SUPREME COURT], which supports classification as medicaments where ingredients, dosage instructions and statutory licensing point to medicinal character. The Baidyanath line [2002 (1) TMI 93 - CEGAT, COURT NO. III, NEW DELHI] cited by Revenue was held inapplicable on the facts where manufacture and licensing as Ayurvedic medicines were established. Applying those legal principles, the Tribunal classified the goods under Chapter 30. [Paras 13] The products are to be classified as Ayurvedic medicines/medicaments under Chapter 30 and not as cosmetics. Liability of loan licensee for excise duty where job worker is manufacturer - HELD THAT:- The Tribunal applied the statutory test that duty is payable by the manufacturer and accepted that M/s. B.D. Enterprises, the job worker, was the manufacturer on a loan licence basis. Noting that the adjudicating authority itself found the job worker located in a rural area and not liable to pay duty, the Tribunal held that liability cannot be fastened on the loan licensee. The decision aligns with authority treating the job worker as manufacturer for excise purposes where manufacturing operations are carried out by the job worker. [Paras 14, 18] The demand for the period prior to August, 2011 is not sustainable against the appellant-company and is set aside. SSI exemption entitlement under Notification No. 08/2003-C.E. - Whether the appellant is entitled to SSI exemption for the period September, 2011 to February, 2012 and whether differential duty is payable from March, 2012 onwards - HELD THAT:- The Tribunal accepted the appellant's submission that total turnover for September 2011 to February 2012 was within the SSI threshold and accordingly entitled to exemption under Notification No. 08/2003-C.E. From March 2012 the appellant had obtained registration and discharged duty classifying the goods under Chapter 30 at the applicable rate; having held the goods to be medicaments, no differential demand is sustainable for that period. The Tribunal therefore granted exemption for the specified SSI period and rejected demands for differential duty from March 2012 onwards. [Paras 15, 16, 18] The appellant is entitled to SSI exemption for September, 2011 to February, 2012; from March, 2012 no differential duty is payable as the goods are correctly classified and duty has been paid accordingly. Imposition of penalty where classification and liability not sustainable - HELD THAT:- Having held that the demands for various periods were not sustainable-either because the appellant was not the manufacturer for the pre August 2011 period, was entitled to SSI exemption for September 2011-February 2012, and had paid appropriate duty from March 2012-the Tribunal concluded that imposition of penalty was not warranted. The Tribunal expressly found no ground for penalty against the company or its Director in the circumstances. [Paras 17, 18] No penalty is imposable on the appellant-company or its Director. Final Conclusion: The appeals are allowed: the goods are classified as Ayurvedic medicaments under Chapter 30; the demands prior to August 2011 are set aside as the job worker was the manufacturer; the appellant is entitled to SSI exemption for September 2011-February 2012; no differential duty is sustainable from March 2012 onwards; and no penalties are imposable.